Status:
UNKNOWN
Endothelial Function Guided Therapy in Patients With Non-obstructive Coronary Artery Disease
Lead Sponsor:
Peking University
Collaborating Sponsors:
Mayo Clinic
Peking University Shougang Hospital
Conditions:
Non-obstructive Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to systematically evaluate the clinical application value of vascular endothelial function examination in patients with non-obstructive coronary artery disease.
Detailed Description
The study will be carried out in two stages. Phase I is mainly intended to evaluate the effects of vascular EFT on the prescription of doctors and the application rate of mid and long-term secondary p...
Eligibility Criteria
Inclusion
- 1\. Age: 18 years or older;
- 2\. Patients with NOCAD defined by CT or CAG results of less than 50% occlusion;
- 3\. Having signed their written informed consent.
Exclusion
- 1\. Left ventricular ejection fraction ≤ 50%;
- 2\. Serious endocrine diseases (severe hyperthyroidism, hypothyroidism);
- 3\. Severe liver diseases (jaundice hepatitis, liver cirrhosis, liver failure);
- 4\. Severe nephropathy (uremia, renal failure);
- 5\. Severe inflammatory diseases (severe infection, lupus erythematosus, etc.);
- 6\. Malignant tumor;
- 7\. Mental disorders or cognitive disorders;
- 8\. Participating in other interventional clinical trials;
- 9\. There are any other factors that the treating doctors think are not suitable for inclusion or completion of this study.
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04013204
Start Date
August 15 2019
End Date
June 1 2024
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Shougang Hospital
Beijing, China